Armstrong, T., Yuan, Y., Wu, J., Mendoza, T., Vera, E., Omuro, A., . . . Gilbert, M. (2018). RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB. Neuro Oncol.
Stile di citazione ChicagoArmstrong, Terri, et al. "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB." Neuro Oncol 2018.
Citazione MLAArmstrong, Terri, et al. "RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB." Neuro Oncol 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.